机构:[1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Canc Hosp, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China[2]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr Canc Hosp, Dept Diagnost Radiol, Beijing, Peoples R China[3]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Pathol,Canc Hosp, Beijing, Peoples R China[4]Chinese Acad Med Sci & Peking Union Med Coll, Dept Endoscopy, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China[5]Peking Union Med Coll Hosp, Dept Med Oncol, Beijing, Peoples R China[6]Sichuan Univ, West China Hosp, Canc Ctr, Dept Abdominal Oncol, Chengdu, Peoples R China四川大学华西医院[7]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Natl Canc Ctr, Beijing, Peoples R China[8]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing, Peoples R China[9]Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Beijing Key Lab Mol Targeted Diag & Therapy Nucl M, Dept Nucl Med, Beijing, Peoples R China[10]Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China[11]Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Beijing, Peoples R China[12]Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China[13]China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China[14]Peking Univ Third Hosp, Peking Univ Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing, Peoples R China[15]Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Peoples R China[16]Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Key Lab Hepatosplen Surg,Minist Educ, Harbin, Peoples R China[17]China Japan Friendship Hosp, Dept Integrat Oncol, Beijing, Peoples R China[18]Nanjing Med Univ, Nanjing Hosp 1, Dept Nucl Med, Nanjing, Peoples R China江苏省人民医院[19]Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China[20]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Gen Surg, Beijing, Peoples R China[21]Peking Univ Third Hosp, Dept Gen Surg, Beijing, Peoples R China[22]Fifth Med Ctr PLA Gen Hosp, Dept Gastrointestinal Oncol, Beijing, Peoples R China[23]Hebei Med Univ, Hosp 4, Dept Gastroenterol, Shijiazhuang, Peoples R China临床科室消化内科河北医科大学第四医院[24]Peking Univ, Dept Nucl Med, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing, Peoples R China[25]Chinese Acad Med Sci & Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Pathol, Beijing, Peoples R China[26]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Pancreat & Gastr Surg,Natl Canc Ctr, Beijing 100021, Peoples R China[27]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,State Key Lab Mol Oncol,Na, Beijing 100021, Peoples R China
Many management strategies are available for pancreatic neuroendocrine neoplasms with liver metastases. However, a lack of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of these strategies. This review presents the viewpoints from an international conference consisting of several expert working groups. The working groups reviewed a series of questions of particular interest to clinicians taking care of patients with pancreatic neuroendocrine neoplasms with liver metastases by reviewing the existing management strategies and literature, evaluating the evidence on which management decisions were based, developing internationally acceptable recommendations for clinical practice, and making recommendations for clinical and research endeavors. The review for each question will be followed by recommendations from the panel.
基金:
National Natural Science Foundation of China [82141127]
第一作者机构:[1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Canc Hosp, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[7]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,Natl Canc Ctr, Beijing, Peoples R China[27]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Hepatobiliary Surg,State Key Lab Mol Oncol,Na, Beijing 100021, Peoples R China
推荐引用方式(GB/T 7714):
Chi Yihebali,Jiang Liming,Shi Susheng,et al.Chinese expert consensus on multidisciplinary diagnosis and treatment of pancreatic neuroendocrine liver metastases[J].JOURNAL OF PANCREATOLOGY.2023,6(4):139-150.doi:10.1097/JP9.0000000000000141.
APA:
Chi, Yihebali,Jiang, Liming,Shi, Susheng,He, Shun,Bai, Chunmei...&Zhao, Hong.(2023).Chinese expert consensus on multidisciplinary diagnosis and treatment of pancreatic neuroendocrine liver metastases.JOURNAL OF PANCREATOLOGY,6,(4)
MLA:
Chi, Yihebali,et al."Chinese expert consensus on multidisciplinary diagnosis and treatment of pancreatic neuroendocrine liver metastases".JOURNAL OF PANCREATOLOGY 6..4(2023):139-150